We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
dMed Global, a full-service Clinical Contract Research Organization (CRO) based in Shanghai, China, and Clinipace Incorporated, a full-service Clinical CRO with headquarters in North Carolina, USA, announced that the two companies will merge.
Innoforce and dMed have signed an agreement under which the two parties agreed to establish a partnership to identify, assess, and collaborate on the development of clinical-stage therapeutics.